Hearing Loss in Adults With Alström Syndrome-Experience From the UK National Alström Service.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
entrez:
28
6
2022
pubmed:
29
6
2022
medline:
30
6
2022
Statut:
ppublish
Résumé
To characterize the patterns of hearing loss and methods of hearing rehabilitation in the UK national cohort of adults with Alström syndrome. Retrospective review of electronic patient records. UK National multi-disciplinary team (MDT) Alström service held at the Queen Elizabeth Hospital, Birmingham. Forty one adult patients with a diagnosis of Alström syndrome, confirmed via ALMS1 gene sequencing, are under ongoing review within the UK National MDT Alström service. Magnitude and type of hearing loss were analyzed using patients' audiometric data. Deterioration of hearing was calculated using serial pure tone audiograms. Methods of hearing rehabilitation used by patients and potential candidacy for cochlear implantation were analyzed. Of 34 patients with available audiograms, all had sensorineural hearing loss (SNHL). Dual sensory (visual and hearing) loss was present in 32/34 (94%) patients. Hearing deteriorated with advancing age, at 1.23 dB/yr. Severe- profound SNHL was present in 9/34 (26%) cases. Air conduction hearing aids were used in 27/34 (79%) cases, and cochlear implants in 2/34 (5%). Alström syndrome is an ultra-rare genetic disorder with progressive, debilitating multi-system manifestations, including SNHL. The UK National MDT Alström service represents one of the largest reported adult cohorts in the world. SNHL in this group was ubiquitous, showing a rapid decline in hearing with age. Annual audiometric assessment to enable early diagnosis of hearing loss and optimum rehabilitation are paramount to minimize the impact of hearing loss in this condition.
Identifiants
pubmed: 35761454
doi: 10.1097/MAO.0000000000003553
pii: 00129492-202207000-00008
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e620-e627Informations de copyright
Copyright © 2022, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
The authors disclose no conflicts of interest.
Références
Alstrom CH, Hallgren B, Nilsson LB, Asander H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand Suppl 1959;129:1–35.
Tahani N, et al. Consensus clinical management guidelines for Alström syndrome. Orphanet J Rare Dis 2020;15:253.
Paisey RB, et al. Rare disorders presenting in the diabetic clinic: an example using audit of the NSCT adult Alström clinics. Pract Diabetes 2011;28:340–3.
Hearn T, et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet 2002;31:79–83.
Collin GB, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 2002;31:74–8.
Li G, et al. A role for Alström syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 2007;3:e8.
Lindsey S, et al. Auditory and otologic profile of Alström syndrome: comprehensive single center data on 38 patients. Am J Med Genet 2017;173:2210–8.
Nasser F, et al. Ophthalmic features of cone-rod dystrophy caused by pathogenic variants in the ALMS1 gene. Acta Ophthalmol 2018;96:e445–54.
Minton JAL, et al. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alström syndrome. J Clin Endocrinol Metab 2006;91:3110–6.
Geberhiwot T, et al. Relative adipose tissue failure in Alström syndrome drives obesity-induced insulin resistance. Diabetes 2021;70:364–76.
Han JC, et al. Comprehensive endocrine-metabolic evaluation of patients with Alström syndrome compared with BMI-matched controls. J Clin Endocrinol Metab 2018;103:2707–19.
Michaud JL, et al. Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr 1996;128:225–9.
Boerwinkle C, et al. Respiratory manifestations in 38 patients with Alström syndrome. Pediatr Pulmonol 2017;52:487–93.
Gathercole LL, et al. Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome. Liver Int 2016;36:1704–12.
Marshall JD, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 2005;165:675–83.
New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Available at: https://www.research.unipd.it/handle/11577/2473166 .
Jagger D, et al. Alström syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity. Hum Mol Genet 2011;20:466–81.
van der Veen EL, et al. Predictors of chronic suppurative otitis media in children. Arch Otolaryngol Head Neck Surg 2006;132:1115–8.
Rajendran V, Roy FG. An overview of motor skill performance and balance in hearing impaired children. Ital J Pediatr 2011;37:33.
Yoshinaga-Itano PDC, Coulter Ba D, Thomson Ma V. The Colorado newborn hearing screening project: effects on speech and language development for children with hearing loss. J Perinatol 2000;20:S132–7.
Werngren-Elgström M, Dehlin O, Iwarsson S. Aspects of quality of life in persons with pre-lingual deafness using sign language: subjective wellbeing, ill-health symptoms, depression and insomnia. Arch Gerontol Geriatr 2003;37:13–24.
Mazzoli M, et al. Recommendations for the description of genetic and audiological data for families with nonsyndromic hereditary hearing impairment. Audiol Med 2003;1:148–50.
NICE. Hearing loss in adults: assessment and management j Guidance j NICE; 2018. Available at: https://www.nice.org.uk/guidance/ng98 .
NICE. Cochlear implants for children and adults with severe to profound deafness j Guidance j NICE; 2019. Available at: https://www.nice.org.uk/guidance/ta566 .
Alstrom Syndrome – Support & Information. Available at: https://www.alstrom.org.uk/ .
Welsh LW. Alström syndrome: progressive deafness and blindness. Ann Otol Rhinol Laryngol 2007;116:281–5.
Brofferio A, et al. Characteristics of cardiomyopathy in Alström syndrome: prospective single-center data on 38 patients. Mol Genet Metab 2017;121:336–43.
Jyothi KNSR, Navya Y, Chandolu VRK, Kumar JNS. A clinical review on Alstrom syndrome. World J Curr Med Pharm Res 2019;32–8.
Niemensivu R, Manchaiah V, Roine RP, Kentala E, Sintonen H. Health-related quality of life in adults with hearing impairment before and after hearing-aid rehabilitation in Finland. Int J Audiol 2015;54:967–75.
Ketterer MC, et al. Binaural hearing rehabilitation improves speech perception, quality of life, tinnitus distress, and psychological comorbidities. Otol Neurotol 2020;41:e563.
Brodie A, Smith B, Ray J. The impact of rehabilitation on quality of life after hearing loss: a systematic review. Eur Arch Otorhinolar- yngol 2018;275:2435–40.
Roth TN, Hanebuth D, Probst R. Prevalence of age-related hearing loss in Europe: a review. Eur Arch Otorhinolaryngol 2011;268:1101–7.
Paisey RB, Leeson-Beevers K. Current management of Alström syndrome and recent advances in treatment. Expert Opin Orphan Drugs 2016;4:747–59.
Turton L, Smith P. Prevalence & characteristics of severe and profound hearing loss in adults in a UK National Health Service clinic. Int J Audiol 2013;52:92–7.
Rethanavelu K, et al. Phenotypic and mutational spectrum of 21 Chinese patients with Alström syndrome. Am J Med Genet A 2020;182:279–88.